-
Thematic Analysis
NewESG (Environmental, Social and Governance) Sentiment Polls Q1 2024 – Thematic Intelligence
ESG (Environmental, Social and Governance) Sentiment Polls Q1 2024 Thematic Report Overview The ESG (Environmental, Social and Governance) sentiment analysis is based on polls designed to help us understand the business community's current sentiment toward ESG (environmental, social, and governance) themes. This is because companies are feeling the pressure to set up ESG performance plans to appeal to consumers and investors. Pressure from the government drives the creation of ESG strategies as well. Governments worldwide are attempting to encourage firms...
-
Product Insights
NewOnward Technologies Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Onward Technologies Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Onward Technologies Ltd (OTL) is a technology company that offers mechanical engineering design and IT consulting services. The company provides engineering design solutions, IT services, product sales and support and staffing services. Its engineering design solutions and services include product design, engineering analysis, manufacturing solutions and engineering change management. OTL offers IT services such as infrastructure support, application development...
-
Product Insights
NewAdvanced Medical Electronics Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Advanced Medical Electronics Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Advanced Medical Electronics Corp (AME) is a medical device company that provide research and development services. The company‘s products include electrocardiograph and spirometer equipment. It also provides battery powered surgical headlamp, wrist-worn pulse oximeter, electroencephalograph, partial polysomnograph, diagnostic spirometer and computerized visual acuity testing. AME offers services such as systems design, embedded design, electronics and instrumentation design, wireless...
-
Thematic Analysis
NewTech Sentiment Polls Q1 2024 – Thematic Intelligence
Tech Sentiment Polls Q1 2024 Thematic Report Overview The sentiment analysis is based on polls designed to help understand the current sentiment of the business community toward emerging and established technologies. The technologies in the ‘Tech Sentiment Polls’ are mature and have been around for decades. They are also widely used across all industries, which makes them more familiar to respondents. Hence, most respondents felt that they either fully understood or had some understanding of all the technologies cited in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eneboparatide in Hypoparathyroidism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eneboparatide in Hypoparathyroidism report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eneboparatide in Hypoparathyroidism Drug Details: Eneboparatide is under development for the treatment...
-
Company Insights
NewKeriMedical SA Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our KeriMedical SA Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. KeriMedical SA specializes in the development and promotion of implants specifically designed for hand and wrist surgery. The company is involved in the design, manufacturing, quality assurance, marketing, and promotion of specialized orthopedic products. It is headquartered in Geneva, Genf, Switzerland. GlobalData's Medical Devices company profile report, “KeriMedical SA Pipeline Insight and Competitive Landscape, 2024" provides information about the company...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HCB-101 in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HCB-101 in Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HCB-101 in Non-Hodgkin Lymphoma Drug Details: HCB-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HCB-101 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HCB-101 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HCB-101 in Solid Tumor Drug Details: HCB-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CX-904 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CX-904 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CX-904 in Colorectal Cancer Drug Details: CX-904 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CX-904 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CX-904 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CX-904 in Solid Tumor Drug Details: CX-904 is under development for...